The latest and most effective treatment to combat rheumatoid arthritis, osteoarticular disorders, and connective tissue diseases, Rhemacell’s deep therapeutic action allows the patient to recover mobility, freedom of action and movement, without the deep pain which the ailment causes.
Rhemacell is a collagen and connective tissue damage regulator. Rhemacell includes the enzymes sulfurylase and choline acetylase, which contribute to restoring the functions lost by damaged connective tissues and toxin-contaminated collagen. Its use is indicated for treating: arthritis, osteoarthritis, gout, herpes, neuralgia, neuritis, and lupus erythematosus.
Deep therapeutic action in cases of osteoarticular and connective tissue diseases.
Rhemacell is the only enzyme product, worldwide, which controls and detains the progress of osteoarticular and connective tissue diseases.
What are the most common symptoms of these diseases?
What can be done to prevent these diseases?
Mainly, go to the doctor for a general check-up. In addition to a healthful diet which includes fruits and vegetables, the following should be taken as preventative measures:
What can be done to cure these diseases?
Treatments differ according to the medical diagnosis.
What can be expected from this treatment?
Being natural products, the positive effects are progressive. Generally, an improvement is noted as of the first month.
What is its formula and what side effects does it have?
Rhemacell is composed of enzymes of plant origin which act directly on the metabolism (organisation) of the osteoarticular system, normalising its functions. Rhemacell does not interact with any other drug. It does not produce side effects, wherefore its use has no limitations or contraindications.
What does one feel when using Rhemacell?
Improvement is slow and progressive, but steady. We have to understand that these diseases tend to be chronic and that what one suffers—many times for years—is not going to be cured in a short time. This non-invasive treatment requires time and consistency to achieve a significant improvement.
How long before effects are noted?
Since these diseases tend to be chronic, one can expect to start feeling an improvement after 30 or 45 days. Consistency in administering the treatment will allow a more pronounced improvement and will detain the progress of the disease.
What benefits are obtained?
In the short term:
More Information |
||
| » Rhemacell 2G » Clinical Information and Pharmacology » Mechanisms of Action » Pharmacokinetics |
» Indications » Contraindications » Toxicity » Clinical Studies |
» Conclusions
» Material and Methods » References |